Skip to content

The application of nerve block anesthesia in the biopsy of perineal prostate

Application of Perennial Nerve Block Anesthesia Combined with Rectal Surface and Subcutaneous Anesthesia in Perineal Prostate Puncture Biopsy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030326
Enrollment
Unknown
Registered
2020-02-28
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

PPNB group:peripheral prostatic nerve block
TPIA group:tip of prostatic infiltration anesthesia

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 60-80 years; 2. Nodules and arbitrary PSA levels were found on digital rectal examination; 3. Rectal ultrasound showed hypoechoic nodules of the prostate or abnormal signals and arbitrary PSA levels on MRI; 4. PSA level > 10 g/L, free free PSA/total PSA (free PSA/total PSA,f/tPSA) and prostate specific antigen density (PSAD); 5. 4 powder g/L<= PSA level <= 10 g/L, abnormal f/tPSA value or abnormal PSAD value; 6. Allowed to prostate puncture.

Exclusion criteria

Exclusion criteria: 1. Prostate volume: transverse diameter, anteroposterior diameter and upper and lower diameter x 0.52 > 80ml; 2. Had taken painkillers before surgery; 3. Patients with acute prostatitis, patients with acute urinary retention and indwresting catheters within the last 2 weeks, patients who underwent lower urinary tract surgery and other related surgeries in the last 3 months. 4. Patients with severe cardiopulmonary, liver and kidney dysfunction, patients with coagulation dysfunction, patients with urinary tract infection, patients with congenital dysplasia, patients with cognitive dysfunction and patients with mental disorders.

Design outcomes

Primary

MeasureTime frame
Degree of pain;Degree of pain;

Secondary

MeasureTime frame
HR and MAP;Complication;

Countries

China

Contacts

Public ContactLibo Xie

Affiliated Hospital of Southwest Medical University

peterxielibo@163.com+86 18208344963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026